Abstract
Background: Galvanic vestibular stimulation (GVS) is being increasingly explored as a non-invasive brain stimulation technique to treat symptoms in Parkinson's disease (PD). To date, behavioral GVS effects in PD have been explored with only two stimulus types, direct current and random noise (RN). The interaction between GVS effects and anti-parkinsonian medication is unknown. In the present study, we designed multisine (ms) stimuli and investigated the effects of ms and RN GVS on motor response time. In comparison to the RN stimulus, the ms stimuli contained sinusoidal components only at a set of desired frequencies and the phases were optimized to improve participants' comfort. We hypothesized GVS motor effects were a function of stimulation frequency, and specifically, that band-limited ms-GVS would result in better motor performance than conventionally used broadband RN-GVS.Materials and Methods: Eighteen PD patients (PDMOFF/PDMON: off-/on-levodopa medication) and 20 healthy controls (HC) performed a simple reaction time task while receiving sub-threshold GVS. Each participant underwent nine stimulation conditions: off-stimulation, RN (4–200 Hz), ms-θ (4–8 Hz), ms-α (8–13 Hz), ms-β (13–30 Hz), ms-γ (30–50 Hz), ms-h1 (50–100 Hz), ms-h2 (100–150 Hz), and ms-h3 (150–200 Hz).Results: The ms-γ resulted in shorter response time (RPT) in both PDMOFF and HC groups compared with the RN. In addition, the RPT of the PDMOFF group decreased during the ms-β while the RPT of the HC group decreased during the ms-α, ms-h1, ms-h2, and ms-h3. There was considerable inter-subject variability in the optimum stimulus type, although the frequency range tended to fall within 8–100 Hz. Levodopa medication significantly reduced the baseline RPT of the PD patients. In contrast to the off-medication state, GVS did not significantly change RPT of the PD patients in the on-medication state.Conclusions: Using band-limited ms-GVS, we demonstrated that the GVS frequency for the best RPT varied considerably across participants and was >30 Hz for half of the PDMOFF patients. Moreover, dopaminergic medication was found to influence GVS effects in PD patients. Our results indicate the common “one-size-fits-all” RN approach is suboptimal for PD, and therefore personalized stimuli aiming to address this variability is warranted to improve GVS effects.
Highlights
Parkinson’s disease (PD) is a progressive disorder marked by the degeneration of dopaminergic neurons in the substantia nigra projecting to the basal ganglia (BG)
There was no significant difference between the PD and healthy controls (HC) groups in Galvanic vestibular stimulation (GVS) threshold level [PD: 0.50 ± 0.24 mA; HC: 0.46 ± 0.18 mA; t(36) = 0.56, P = 0.58]
For PD participants, no significant correlations were found between their thresholds and clinical scores
Summary
Parkinson’s disease (PD) is a progressive disorder marked by the degeneration of dopaminergic neurons in the substantia nigra projecting to the basal ganglia (BG). Dopamine-based pharmacologic treatments such as levodopa remain the gold standard for symptomatic treatment of PD [2] and are robust and effective in improving motor function, in the early stages of the disease. Some symptoms such as gait and balance dysfunction may be poorly responsive to dopaminergic medication [3], and many people who have been treated with levodopa for prolonged periods may experience complications such as dyskinesias and motor fluctuations [2]. We hypothesized GVS motor effects were a function of stimulation frequency, and that band-limited ms-GVS would result in better motor performance than conventionally used broadband RN-GVS
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
